| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.07 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.051 | 0.07 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.08 |